Clinical Trial Update: High-Dose Methotrexate in Treating Young Patients With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update on high-dose methotrexate in young patients with solid tumors; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Sarcoma

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Children's Cancer and Leukaemia Group | Conditions: Brain and Central Nervous System Tumors, Sarcoma | Phase 1 | Status: COMPLETED